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Abstract— In the molecular era the management of cancer is no 
more a plan based on simple guidelines. Clinical findings, tumor 
characteristics, and molecular markers are integrated to identify 
different risk categories, based on which treatment is planned for 
each individual case. 
This paper aims at developing a fuzzy decision support system 
(DSS)  to  guide  the  doctors  for  the  risk  stratification  of  breast 
cancer, which is expected to have a great impact on treatment 
decision  and  to  minimize  individual  variations  in  selecting  the 
optimal treatment for a particular case.  
The developed system was based on clinical practice of Oncology 
Center Mansoura University (OCMU)  
This  system  has  six  input variables  (Her2,  hormone  receptors, 
age, tumor grade, tumor size, and lymph node) and one output 
variable (risk status). The output variable is a value from 1 to 4; 
representing low  risk  status,  intermediate  risk  status and  high 
risk  status.  This  system  uses  Mamdani  inference  method  and 
simulation applied in MATLAB R2009b fuzzy logic toolbox. 
Keywords: Decision Support System; Breast Cancer; Fuzzy Logic; 
Mamdani Inference;  
I.  INTRODUCTION 
In recent years, the methods of Artificial Intelligence have 
largely been used in the different areas including the medical 
applications.  In  the  medical  field,  many  decision  support 
systems (DSSs) were designed, as Aaphelp, Internist I, Mycin, 
Emycin,  Casnet/Glaucoma,  Pip,  Dxplain,  Quick  Medical 
Reference,  Isabel,  Refiner  Series  System    and  PMA 
[1,2,3,4,5,6,7]  which  assist  physicians  in  their  decisions  for 
diagnosis  and treatment of different diseases. 
In cancer management many DSSs have been developed as 
ONCOCIN [1], OASIS, Lisa [8, 9]. 
The  diagnosis  of  disease  involves  several  levels  of 
uncertainty  and  imprecision  [10].  According  to  Aristotelian 
logic, for a given proposition or state we only have two logical 
values: true-false, black-white, 1-0. In real life, things are not 
either black or white, but most of the times are grey. Thus, in 
many  practical  situations,  it  is  convenient  to  consider 
intermediate  logical  values.  Uncertainty  is  now  considered 
essential to science and fuzzy logic is a way to model and deal 
with it using natural language. We can say that fuzzy logic is a 
qualitative computational approach. Fuzzy logic is a method to 
render precise what is imprecise in the world of medicine. 
Many medical applications use  fuzzy logic as  CADIAG 
[11], MILORD [11], DOCTORMOON [12], TxDENT [13], 
MedFrame/CADIAG-IV [14], FuzzyTempToxopert [14] and 
MDSS [15].  
In  the  field  of  breast  cancer,  DSS  is  very  important,  as 
breast cancer is the most common cause of cancer death among 
women worldwide, in Egypt, breast cancer is the most common 
cancer among women; representing 18.9% of total cancer cases 
[16]. The National Cancer Institute (NCI) reported a series of 
10556 patients with breast cancer during the year 2001. 
The diagnoses have a lot of confounding alternatives, some 
of  them  are  uncertain  as  Her2-neu  positivity,  hormone 
receptor status and age. Therefore the treatment planning is 
based on the interaction of a lot of compound variables with 
complex outcomes.  
We planned to use fuzzy logic to deal with uncertainty for 
diagnosis risk status of breast cancer.  
This  paper  is  organized  as  follows;  general  structure  of 
fuzzy logic system is introduced in section II, design of the 
system  is  presented  in  section  III  and  test  system  and 
discussion are presented in section IV. 
II.  GENERAL STRUCTURE OF FUZZY LOGIC SYSTEM 
Fuzzy  logic  system  as  seen  in  Fig.  1  consists  of  the 
following modules [17]: 
Figure 1.   Structure of Fuzzy Logic System. 
1.   Fuzzification:  -  is  the  operation  of  transforming  a 
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input or measured values into linguistic concepts by 
using suitable membership functions. 
2.   Inference Engine and Rule base:- Once the inputs are 
fuzzified,  the  corresponding  inputs  fuzzy  sets  are 
passed to the inference engine that processes current 
inputs using the rules retrieved from the rule base. 
3.   Defuzzifcation:- At the output of the fuzzy inference 
there will always be a fuzzy set that is obtained by the 
composition of the fuzzy sets output by each of the 
rules. In order to be used in the real world, the fuzzy 
output needs to be interfaced to the crisp domain by 
the  defuzzifier  by  using  suitable  membership 
functions. 
III.  DESIGN OF THE SYSTEM 
In this section, we show the fuzzy decision support system 
designing, membership functions, fuzzy rule base, fuzzification 
and defuzzification.  
The  most  important  application  of  fuzzy  system  (fuzzy 
logic)  is  in  uncertain  issues.  When  a  problem  has  dynamic 
behavior,  fuzzy  logic  is  a  suitable  tool  that  deals  with  this 
problem. First step of fuzzy DSS designing is determination of 
input and output variables. There are six input variables and 
one output variable. After that, we must design membership 
functions (MF) of all variables. These membership functions 
determine the membership of objects to fuzzy sets. 
At  first,  we  will  describe  the  input  variables  with  their 
membership functions. In second step, we introduce the output 
variable with its membership functions. In next section, paper 
shows the rules of system and Fuzzification , Defuzzification 
process. 
A.  Input Variables Are: 
1)  HER2:  Stands  for  "Human  Epidermal  growth  factor 
Receptor 2" and is a protein giving higher aggressiveness in 
breast cancers [18].This input variable has two fuzzy sets are 
"Negative" and "Positive". Membership functions of them are 
trapezoidal. Fuzzy sets Range of HER2 are identified in table I 
and membership functions for fuzzy sets are identified in Fig. 2  
TABLE I.   FUZZY SETS OF HER2 FACTOR 
Input Field  Range  Fuzzy set 
Her2  
<=1.5  Negative 
1.5 - 3  May be  Negative or Positive 
>=3  Positive 
Figure 2.   Membership Functions for HER2 
 
µNegative(x) = 
 
 
µPositive(x) =  
 
2)  Hormone  Receptor:  Identifies  sensitivity  of  breast  to 
hormone  [19].  This  input  variable  has  four  fuzzy  sets  are 
Negative,  Weak  Positive,  Moderate  Positive  and  Strong 
Positive.  Membership  functions  of  Negative  and  Strong 
Positive fuzzy sets are  trapezoidal, membership functions  of 
Weak  Positive  and  Moderate  Positive  are  triangle.  Table  II 
identifies  fuzzy  sets  range  and  Fig.  3  identifies  membership 
functions of fuzzy sets. 
TABLE II.   FUZZY SETS OF HORMONE RECEPTORS 
Input Field 
identifie
s fuzzy 
sets 
Range 
of 
Hormon
e 
Recepto
r and 
figure 3 
identifie
s  
member
ship 
function
s for 
fuzzy 
sets. 
Input 
Field 
Range  Fuzzy set 
Hormone 
<=10  Negative 
10 - 15  May be Negative or Weak Positive 
15 - 20  May be  Weak Positive or  Moderate Positive 
20 - 35  Moderate Positive 
35 - 40  May be  Moderate Positive or Strong Positive 
>=40  Strong Positive 
 
 
Figure 3.   Membership Functions for Hormone Receptors 
 
 
µNegative(x) =        
 
 
 
µWeak Positive(x) =     
 
   
 
µModerate Positive(x) =  
 
0                   x<=1.5 
(x-1.5)/1.5   1.5<x<3 
1                   x >= 3 
 
1                  x<=1.5 
(3-x)/1.5     1.5<x<3 
0                  x >= 3 
 
1                   x<=5 
(15-x)/10      5<x<15 
0                   x >= 15 
  0                   x<=10  
(x-10)/5       10<x<15 
1                   x = 15 
(20-x)/5       15<x<20 
0                   x>=20 
0                     x<=15  
(x-15)/12.5    15<x<27.5 
1                     x = 27.5 
(40-x)/12.5    27.5<x<40 
0                     x>=40 
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µStrong Positive(x) = 
 
3)  Risk Age: This input variable has three fuzzy sets, are 
Very High, High And Low Risk age. Membership functions of 
these fuzzy sets are trapezoidal. Table III identifies fuzzy sets 
range and Fig. 4 identifies membership functions of them 
TABLE III.   FUZZY SETS OF RISK AGE 
Input Field  Range  Fuzzy set 
Age 
<=20  Very High Risk 
20 - 30  May be Very High Risk or High Risk 
30 - 35  High Risk 
35 - 45  May be High Risk or Low Risk 
>=45  Low Risk 
Figure 4.   Membership Functions for Risk Age 
 
µVeryhighRisk(x) = 
 
 
 
 
µHighRisk(x) = 
 
 
 
 
µLowRisk(x) = 
 
 
4)  Tumor Grade: A description of a tumor based on how 
abnormal the cancer cells look under a microscope and how 
quickly the tumor is likely to grow and spread [20]. Grading 
systems  are  different  for  each  type  of  cancer.  This  input 
variable  has  three  fuzzy  sets  Grade1,  Grade2  and  Grade3. 
Membership  functions  of  these  fuzzy  sets  are  trapezoidal. 
Table  IV  identifies  fuzzy  sets  range  and  Fig.  5  identifies 
membership functions of them 
 
 
 
TABLE IV.   FUZZY SETS OF TUMOR GRADE 
Input Field  Range  Fuzzy set 
Grade 
<=4  Grade1 
4 - 5.5  May be Grade1 or  Grade2 
5.5 - 6  Grade2 
6 - 7.5  May be Grade2 or Grade3 
>=7.5   Grade3 
Figure 5.   Membership Functions for Tumor Grade 
 
5)  Lymph  Node:  A  lymph  node  is  part  of  the  body‟s 
lymphatic  system,  in  the  lymphatic  system,  a  network  of 
lymph vessels carries clear fluid called lymph, lymph vessels 
lead to lymph nodes; with it cancer cells are likely to spread 
from the primary tumor [21]. This input variable is Zero or has 
two fuzzy sets are Intermediate Number(Intermediate No.) and 
High  Number(High  No.),  membership  functions  for  these 
fuzzy sets are trapezoidal. 
Table V identifies fuzzy sets range of lymph node variable and 
Fig. 6 identifies membership functions of them. 
TABLE V.   FUZZY SETS OF LYMPH NODE 
Input Field  Range  Fuzzy set 
Lymph Node 
1 - 2  Intermediate No. 
2 - 10  May be Intermediate No. or High No. 
>=10  High No. 
 
 
µIntermediateNo. (x) =  
 
 
µHighNo. (x) = 
0                      x<=35 
x-35)/ 5          35<x<40 
1                      x >=40 
 
0                   x<=20 
(x-20)/10     20<x<30 
1                  30=<x<=35 
(45-x)/10     35<x<45 
0                   x>=45                   
1                  x<=20  
(30-x)/10    20<x<30 
0                   x >= 30 
0                   x<=35 
(x-35)/15     35<x<50 
1                   x >= 50 
 
1              1<=x<=2 
(10-x)/8   2<x<10 
0              x>=10  
 
0               x<=2      
(x-2)/10    2<x<12 
1               x>=12 
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Figure 6.   Membership Functions for Lymph Node   
6)  Tumor  Size:  This  input  variable  has  two  fuzzy  sets 
Small Size and Intermediate Size, membership functions for 
these fuzzy sets are trapezoidal, Table VI identifies fuzzy sets 
range of tumor size variable and Fig. 7 identifies membership 
functions of them. 
TABLE VI.   FUZZY SETS OF TUMOR SIZE 
Input Field  Range  Fuzzy set 
Tumor Size 
<=2  Small Size 
2 - 4  May be Small Size or Intermediate Size 
>=4  Intermediate Size 
 
Figure 7.   Membership Functions for Tumor Size                
µSmallSize(x) =  
 
 
µIntermediateSize(x) = 
 
B.   Output Variable Is: 
The "goal" of the system is to identify risk status of breast 
cancer recurrence or mortality in early diagnosed patients. The 
output variable is a value from 1 to 4; representing Low Risk 
status,  Intermediate  Risk  status  and  High  Risk  status.  By 
increasing  the  value,  tumor  risk  increases.  This  output  has 
three fuzzy sets Low Risk, Intermediate Risk And High Risk; 
table VII identifies these fuzzy sets and its range. 
The membership functions of these fuzzy sets are triangle 
as shown in Fig. 8. 
TABLE VII.    FUZZY SETS OF OUTPUT VARIABLE RISK STATUS 
Output 
Field 
Range  Fuzzy set 
Risk Status 
0 - 2  Low Risk 
1 - 3  Intermediate Risk 
2 - 4  High Risk 
Figure 8.   Membership Function For Output Variable Risk Status 
C.  Fuzzy Rule Base 
The Rules Base is determined by the help of consultant 
doctors of the OCMU Center. 
The rule base consists of 14 rules that determine the Risk 
status  (High  Risk,  Intermediate  Risk  and  Low  Risk)  by 
evaluation of the input variables mentioned above. Hormone 
receptor  positivity  level  has  no  value  in  risk  status 
characterization; however it plays an important role in further 
treatment decision. The rule base is shown in Table VIII 
D.  Fuzzification and Defuzzification  
This  system  depends  on  Mamdani  model  for  inference 
mechanism, in it and method is minimum (this system doesn't 
contains or operator), Implication method is minimum which 
involves defining the consequence as an output fuzzy set.  
This  can  only  be  achieved  after  each  rule  has  been 
evaluated and is allowed contribute its „weight‟ in determining 
the  output  fuzzy  set,  Aggregation  method  between  rules  is 
maximum  to  combine  output  fuzzy  set,  so  Fuzzification 
method  here  is  max-min  and  Defuzzification  method  is 
centroid . 
IV.  TEST SYSTEM AND DISCUSSION 
System has been tested by consultant oncologists and here 
is one of tested values as shown in Table IX and Fig. 9 
 
1              x<=1 
(4-x)/3     1<x<4 
0              x>=4 
 
0             x<=2 
(x-2)/8    2<x<10  
1             x>=10 
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TABLE VIII.   RULE BASE OF THE SYSTEM 
Rule 
 NO 
Her2  Hormone 
Receptors 
Risk Age  Grade  Tumor  
Size 
Lymph Node  Risk Status 
1  Negative  Weak Positive  Low  Grade1  Small  Zero  Low Risk 
2  Negative  Weak Positive  High  Grade1  Small  Zero  Low Risk 
3  Negative  Moderate Positive  Low  Grade1  Small  Zero  Low Risk 
4  Negative  Moderate Positive  High  Grade1  Small  Zero  Low Risk 
5  Negative  Strong Positive  Low  Grade1  Small  Zero  Low Risk 
6  Negative  Strong Positive  High  Grade1  Small  Zero  Low Risk 
7  Negative  Any  Any  Grade2  Any  Zero  Intermediate Risk 
8  Negative  Any  Any  Grade3  Any  Zero  Intermediate Risk 
9  Negative  Any  Any  Any  Intermediate  Zero  Intermediate Risk 
10  Negative  Any  Very High  Any  Any  Zero  Intermediate Risk 
11  Negative  Any  Any  Any  Any  Intermediate No.  Intermediate Risk 
12  Positive  Any  Any  Any  Any  Zero  Intermediate Risk 
13  Positive  Any  Any  Any  Any  Intermediate No.  High Risk 
14  Any  Any  Any  Any  Any  High No.  High Risk 
TABLE IX.   TESTED VALUES 
Her2  Hormone 
Receptors 
Age  Grade  Tumor Size  Lymph 
 Node 
Risk Status 
4  35  35  4  3  5  3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.   Result Of Tested Values 
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And Fig. 10, 11, 12 and 13 shown surface viewer of some 
fields as follow:- 
 
Figure 10. Surface Viewer of HER2 and Lymph Node 
Figure 12. Surface Viewer of HER 2 and Tumor Grade 
Figure 13. Surface Viewer of Hormone Receptor and Lymph Node 
Figure 11. Surface Viewer of Hormone Receptor  and Lymph Nod 
V.  CONCLUSION AND FUTURE WORK 
This  paper  describes  design  of  fuzzy  decision  support 
system  for  identification  of  breast  cancer  risk  status  in 
situations of data diversity and imprecision, which can be used 
by specialized doctors for cancer treatment. 
The system design with based on membership functions, 
input variables, output variables and rule base. This system has 
been tested and approved by consultant oncologists in OCMU 
(Oncology Center Mansoura University). 
In  future  this  system  can  be  applied  for  other  types  of 
cancers. In addition it can integrate the more complex evolving 
molecular data in cancer diagnosis.  
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